Aspivix
Renens
About Aspivix
ASPIVIX is developing a new generation of medical devices that make gynecological procedures gentler and safer for women and gynecologists. The first device, CAREVIX, is designed to prevent cervix bleeding using a suction technology to replace traumatic tenaculum (forceps).
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $13.1M
- Funding stage: Early Stage Venture
- Last round: Debt Financing (Jun 2024)
- Website: aspivix.com
- Phone: [email protected]
Industries & Categories
Biotechnology, Health Care, Medical, Medical Device, Women's
Social Profiles
Canonical: https://fsome.com/organization/aspivix-18401 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.